Skip to main content
. 2022 Nov 10;14(11):e31324. doi: 10.7759/cureus.31324

Table 3. Summary of articles used.

SLE: systemic lupus erythematosus

Reference number Author, year, and type Purpose Results
[13] Catanzaro et al., 2018, review article Study the immune modulatory role of curcumin Active components of medicinal plants can be used for treating several inflammatory autoimmune diseases in the long run
[5] Pan et al., 2020, literature review Explain the pathogenesis of SLE, and decide the treatment options based on the same Understanding the mechanism of SLE evolution helps decide the target for drug action
[1] Beccastrini et al., 2013, review article Understand the immunopathogenesis of lupus, and understand the treatment options Treatment can be tailored to various subsets of patients, depending on their preferences and response to treatment
[8] Giraldo et al., 2012, review article Analyze the mechanism of lupus and the molecules used for its management Several alternative newer drugs can be used for patient management
[2] Rivas-Larrauri and Yamazaki-Nakashimada, 2016, review article Study various genetic defects associated with SLE to individualize treatment Many genetic factors play a role in SLE development
[14] Connolly and Hakonarson, 2012, literature review Study genomic approaches toward SLE Genetics can play a significant role in the development of lupus
[15] Nagafuchi et al., 2019, review article Discuss immune profiling of lupus and its role in medical management Biomarkers will help guide the treatment and assessment of improvement
[3] Tsang-A-Sjoe and Bultink, 2021, literature review Compare newer drugs to decide on lupus treatment options Newer treatment options are required due to toxic reactions of currently approved drugs